Whats new

Whats new.

Maxim Group - New P2/3 AIPAC-003 Study Initiated with More Aggressive Dosing & OS Primary in Breast Cancer; Buy, $8 tgt (Jason McCarthy, PhD)

March 14th 2023

For a copy of this analyst report please contact your Maxim advisor

Go back